Paces Ferry Wealth Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
Other funds holding ARKG
MCM
CAN
Paces Ferry Wealth Advisors's ARKG Position: Q4 2020 in Review
Paces Ferry Wealth Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q4 2020, closing a stake of 144 shares — an estimated $9K sold.
Paces Ferry Wealth Advisors first reported a position in ARKG in Q3 2020 and held it in 1 quarter. The position peaked at $9K in Q3 2020. 414 funds tracked by Wall St. Rank hold ARKG as of Q4 2020.
- Paces Ferry Wealth Advisors reported no remaining ARK Genomic Revolution ETF position as of Q4 2020 after selling out during the quarter.
- Paces Ferry Wealth Advisors sold 144 ARK Genomic Revolution ETF shares in Q4 2020, an estimated $9K.
- Paces Ferry Wealth Advisors first reported a position in ARK Genomic Revolution ETF in Q3 2020 and held it in 1 quarter.
- Paces Ferry Wealth Advisors's ARK Genomic Revolution ETF position peaked at $9K in Q3 2020.
- 414 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q4 2020.
Based on Paces Ferry Wealth Advisors's 13F filing for Q4 2020, filed 5 Mar 2021.